Advanced search
Publication Cover
Therapeutic Delivery Volume 3, 2012 - Issue 8
Submit an article Journal homepage
216
Views
0
CrossRef citations to date
0
Altmetric
Perspective

Dendritic Nanoparticles: the Next Generation of nanocarriers?

Ryan M Pearsona Department of Biopharmaceutical Sciences University of Illinois at Chicago College of Pharmacy833 S. Wood St. (MC 865)ChicagoIL60612USA
,
Suhair Sunoqrota Department of Biopharmaceutical Sciences University of Illinois at Chicago College of Pharmacy833 S. Wood St. (MC 865)ChicagoIL60612USA
,
Hao-jui Hsua Department of Biopharmaceutical Sciences University of Illinois at Chicago College of Pharmacy833 S. Wood St. (MC 865)ChicagoIL60612USA
,
Jin Woo Baea Department of Biopharmaceutical Sciences University of Illinois at Chicago College of Pharmacy833 S. Wood St. (MC 865)ChicagoIL60612USA
&
Seungpyo Hongb Department of Biopharmaceutical Sciences University of Illinois at Chicago College of Pharmacy833 S. Wood St. (MC 865)[email protected]
Pages 941-959 | Published online: 23 Aug 2012

References

  • Lee CC , MackayJA, FrechetJMJ, SzokaFC. Designing dendrimers for biological applications. Nat. Biotechnol.23(12), 1517–1526 (2005).
  • Esfand R , TomaliaDA. Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov. Today6(8), 427–436 (2001).
  • Svenson S , TomaliaDA. Commentary – dendrimers in biomedical applications – reflections on the field. Adv. Drug Deliv. Rev.57(15), 2106–2129 (2005).
  • Gao C , YanD. Hyperbranched polymers: from synthesis to applications. Prog. Polymer Sci.29(3), 183–275 (2004).
  • Jang WD , SelimKMK, LeeCH, KangIK. Bioinspired application of dendrimers: from bio-mimicry to biomedical applications. Prog. Polymer Sci.34(1), 1–23 (2009).
  • Baars MWPL , KarlssonAJ, SorokinV, De Waal BFW, Meijer EW. Supramolecular modification of the periphery of dendrimers resulting in rigidity and functionality. Angew. Chem. Int. Ed.39(23), 4262–4265 (2000).
  • Hong S , LeroueilPR, MajorosIJ, OrrBG, BakerJR, HollMMB. The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem. Biol.14(1), 107–115 (2007).
  • Myung J , GajjarKA, SaricJ, EddingtonDT, HongS. Dendrimer-mediated multivalent binding for the enhanced capture of tumor cells. Angew. Chem. Int. Ed.50(49), 11769–11772 (2011).
  • Boas U , HeegaardPM. Dendrimers in drug research. Chem. Soc. Rev.33(1), 43–63 (2004).
  • Hong S , BielinskaAU, MeckeAet al. Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. Bioconjug. Chem. 15(4), 774–782 (2004).
  • Hong S , RattanR, MajorosIJet al. The role of ganglioside GM(1) in cellular internalization mechanisms of poly(amidoamine) dendrimers. Bioconjug. Chem. 20(8), 1503–1513 (2009).
  • Patri AK , Kukowska-LatalloJF, BakerJR. Targeted drug delivery with dendrimers: Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv. Drug Deliv. Rev.57(15), 2203–2214 (2005).
  • Cheng Y , ZhaoL, LiY, XuT. Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives. Chem. Soc. Rev.40(5), 2673–2703 (2011).
  • Heegaard PMH , BoasU, SorensenNS. Dendrimers for vaccine and immunostimulatory uses. A review. Bioconjug. Chem.21(3), 405–418 (2009).
  • Tekade RK , KumarPV, JainNK. Dendrimers in oncology: an expanding horizon. Chem. Rev.109(1), 49–87 (2009).
  • Khandare J , CalderonM, DagiaNM, HaagR. Multifunctional dendritic polymers in nanomedicine: opportunities and challenges. Chem. Soc. Rev.41(7), 2824–2848 (2012).
  • Kaminskas LM , PorterCJH. Targeting the lymphatics using dendritic polymers (dendrimers). Adv. Drug Deliv. Rev.63(10–11), 890–900 (2011).
  • Wurm F , FreyH. Linear-dendritic block copolymers: the state of the art and exciting perspectives. Prog. Polymer Sci.36(1), 1–52 (2011).
  • Rosen BM , WilsonCJ, WilsonDA, PetercaM, ImamMR, PercecV. Dendron-mediated self-assembly, disassembly, and self-organization of complex systems. Chem. Rev.109(11), 6275–6540 (2009).
  • Bae JW , PearsonRM, PatraNet al. Dendron-mediated self-assembly of highly PEGylated block copolymers: a modular nanocarrier platform. Chem. Commun. 47(37), 10302–10304 (2011).
  • Poon Z , ChenS, EnglerACet al. Ligand-clustered “patchy” nanoparticles for modulated cellular uptake and in vivo tumor targeting. Angew. Chem. Int. Ed. 49(40), 7266–7270 (2010).
  • Percec V , WilsonDA, LeowanawatPet al. Self-assembly of Janus dendrimers into uniform dendrimersomes and other complex architectures. Science 328(5981), 1009–1014 (2010).
  • Peterca M , PercecV, LeowanawatP, BertinA. Predicting the size and properties of dendrimersomes from the lamellar structure of their amphiphilic Janus dendrimers. J. Am. Chem. Soc.133(50), 20507–20520 (2011).
  • Sunoqrot S , BaeJW, PearsonRMet al. Temporal control over cellular targeting through hybridization of folate-targeted dendrimers and PEG-PLA nanoparticles. Biomacromolecules 13(4), 1223–1230 (2012).
  • Tomalia DA , BakerH, DewaldJet al. A new class of polymers – starburst-dendritic macromolecules. Polymer J. 17(1), 117–132 (1985).
  • Hawker CJ , FréchetJMJ. Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules. J. Am. Chem. Soc.112(21), 7638–7647 (1990).
  • Bosman AW , JanssenHM, MeijerEW. About dendrimers: structure, physical properties, and applications. Chem. Rev.99(7), 1665–1688 (1999).
  • Wooley KL , HawkerCJ, FrechetJMJ. Hyperbranched macromolecules via a novel double-stage convergent growth approach. J. Am. Chem. Soc.113(11), 4252–4261 (1991).
  • Freeman AW , FrechetJMJ. A rapid, orthogonal synthesis of poly(benzyl ester) dendrimers via an “activated” monomer approach. Org. Lett.1(4), 685–688 (1999).
  • Kawaguchi T , WalkerKL, WilkinsCL, MooreJS. Double exponential dendrimer growth. J. Am. Chem. Soc.117(8), 2159–2165 (1995).
  • Zeng F , ZimmermanSC. Rapid synthesis of dendrimers by an orthogonal coupling strategy. J. Am. Chem. Soc.118(22), 5326–5327 (1996).
  • Duncan R , IzzoL. Dendrimer biocompatibility and toxicity. Adv. Drug Deliv. Rev.57(15), 2215–2237 (2005).
  • Malik N , WiwattanapatapeeR, KlopschRet al. Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J. Control. Release 65(1–2), 133–148 (2000).
  • Hong S , LeroueilPR, JanusEKet al. Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability. Bioconjug. Chem. 17(3), 728–734 (2006).
  • Jain K , KesharwaniP, GuptaU, JainNK. Dendrimer toxicity: let‘s meet the challenge. Int. J. Pharm.394(1–2), 122–142 (2010).
  • Ihre H , Padilla De Jesus OL, Frechet JM. Fast and convenient divergent synthesis of aliphatic ester dendrimers by anhydride coupling. J. Am. Chem. Soc.123(25), 5908–5917 (2001).
  • Ihre HR , Padilla De Jesus OL, Szoka FC Jr, Frechet JM. Polyester dendritic systems for drug delivery applications: design, synthesis, and characterization. Bioconjug. Chem.13(3), 443–452 (2002).
  • Winnicka K , BielawskiK, RusakM, BielawskaA. The effect of generation 2 and 3 poly(amidoamine) dendrimers on viability of human breast cancer cells. J. Health Sci.55(2), 169–177 (2009).
  • Lee CC , GilliesER, FoxMEet al. A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proc. Natl Acad. Sci. USA 103(45), 16649–16654 (2006).
  • Padilla De Jesus OL , IhreHR, GagneL, FrechetJM, SzokaFC Jr. Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation. Bioconjug. Chem.13(3), 453–461 (2002).
  • Wijagkanalan W , KawakamiS, HashidaM. Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations. Pharm. Res.28(7), 1500–1519 (2011).
  • Kaminskas LM , BoydBJ, PorterCJH. Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties. Nanomedicine6(6), 1063–1084 (2011).
  • Margerum LD , CampionBK, KooMet al. Gadolinium(III) DO3A macrocycles and polyethylene glycol coupled to dendrimers – effect of molecular weight on physical and biological properties of macromolecular magnetic resonance imaging contrast agents. J. Alloys Compounds 249(1–2), 185–190 (1997).
  • Kaminskas LM , BoydBJ, KarellasPet al. Impact of surface derivatization of poly-L-lysine dendrimers with anionic arylsulfonate or succinate groups on intravenous pharmacokinetics and disposition. Mol. Pharm. 4(6), 949–961 (2007).
  • Owens DE III, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm.307(1), 93–102 (2006).
  • Kojima C , ReginoC, UmedaY, KobayashiH, KonoK. Influence of dendrimer generation and polyethylene glycol length on the biodistribution of PEGylated dendrimers. Int. J. Pharm.383(1–2), 293–296 (2010).
  • Kaminskas LM , BoydBJ, KarellasPet al. The impact of molecular weight and peg chain length on the systemic pharmacokinetics of PEGylated poly L-lysine dendrimers. Mol. Pharm. 5(3), 449–463 (2008).
  • Poon Z , LeeJA, HuangS, PrevostRJ, HammondPT. Highly stable, ligand-clustered “patchy” micelle nanocarriers for systemic tumor targeting. Nanomedicine7(2), 201–209 (2011).
  • Gillies ER , DyE, FrechetJMJ, SzokaFC. Biological evaluation of polyester dendrimer: poly(ethylene oxide) “bow-tie” hybrids with tunable molecular weight and architecture. Mol. Pharm.2(2), 129–138 (2005).
  • Zhao F , ZhaoY, LiuY, ChangX, ChenC, ZhaoY. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small7(10), 1322–1337 (2011).
  • Wolinsky JB , GrinstaffMW. Therapeutic and diagnostic applications of dendrimers for cancer treatment. Adv. Drug Deliv. Rev.60(9), 1037–1055 (2008).
  • Kitchens KM , KolhatkarIB, SwaanPW, GhandehariH. Endocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across Caco-2 cells. Mol. Pharm.5(2), 364–369 (2008).
  • Albertazzi L , SerresiM, AlbaneseA, BeltramF. Dendrimer internalization and intracellular trafficking in living cells. Mol. Pharm.7(3), 680–688 (2010).
  • Perumal OP , InapagollaR, KannanS, KannanRM. The effect of surface functionality on cellular trafficking of dendrimers. Biomaterials29(24–25), 3469–3476 (2008).
  • Rajendran L , KnolkerHJ, SimonsK. Subcellular targeting strategies for drug design and delivery. Nat. Rev. Drug Discov.9(1), 29–42 (2010).
  • Mammen M , ChoiSK, WhitesidesGM. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Ed.37(20), 2755–2794 (1998).
  • Kiessling LL , GestwickiJE, StrongLE. Synthetic multivalent ligands in the exploration of cell-surface interactions. Curr. Opin. Chem. Biol.4(6), 696–703 (2000).
  • Kiessling LL , GestwickiJE, StrongLE. Synthetic multivalent ligands as probes of signal transduction. Angew. Chem. Int. Ed.45(15), 2348–2368 (2006).
  • Vance D , MartinJ, PatkeS, KaneRS. The design of polyvalent scaffolds for targeted delivery. Adv. Drug Deliv. Rev.61(11), 931–939 (2009).
  • Mecke A , LeeI, BakerJR Jr, Holl MMB, Orr BG. Deformability of poly(amidoamine) dendrimers. Eur. Phys. J. E. Soft Matter Biol. Phys.14(1), 7–16 (2004).
  • Page D , AravindS, RoyR. Synthesis and lectin binding properties of dendritic mannopyranoside. Chem. Commun. (16), 1913–1914 (1996).
  • Ashton PR , HounsellEF, JayaramanNet al. Synthesis and biological evaluation of α-D-mannopyranoside-containing dendrimers. J. Org. Chem. 63(10), 3429–3437 (1998).
  • Kane RS . Thermodynamics of multivalent interactions: influence of the linker. Langmuir26(11), 8636–8640 (2010).
  • Shewmake TA , SolisFJ, GilliesRJ, CaplanMR. Effects of linker length and flexibility on multivalent targeting. Biomacromolecules9(11), 3057–3064 (2008).
  • Kim YS , LeeJH, RyuJ, KimDJ. Multivalent and multifunctional ligands to β-amyloid. Curr. Pharm. Des.15(6), 637–658 (2009).
  • Rele SM , CuiWX, WangLCet al. Dendrimer-like PEO glycopolymers exhibit anti-inflammatory properties. J. Am. Chem. Soc. 127(29), 10132–10133 (2005).
  • Gestwicki JE , CairoCW, StrongLE, OetjenKA, KiesslingLL. Influencing receptor-ligand binding mechanisms with multivalent ligand architecture. J. Am. Chem. Soc.124(50), 14922–14933 (2002).
  • Dijkgraaf I , RijndersAY, SoedeAet al. Synthesis of DOTA-conjugated multivalent cyclic-RGD peptide dendrimers via 1,3-dipolar cycloaddition and their biological evaluation: implications for tumor targeting and tumor imaging purposes. Org. Biomol. Chem. 5(6), 935–944 (2007).
  • McNerny DQ , Kukowska-LatalloJF, MullenDGet al. RGD dendron bodies; synthetic avidity agents with defined and potentially interchangeable effector sites that can substitute for antibodies. Bioconjug. Chem. 20(10), 1853–1859 (2009).
  • Martin AL , LiB, GilliesER. Surface functionalization of nanomaterials with dendritic groups: toward enhanced binding to biological targets. J. Am. Chem. Soc.131(2), 734–741 (2008).
  • Vannucci L , FiserovaA, SadalapureKet al. Effects of N-acetyl-glucosamine-coated glycodendrimers as biological modulators in the B16F10 melanoma model in vivo. Int. J. Oncol. 23(2), 285–296 (2003).
  • Fox ME , SzokaFC, FrechetJMJ. Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc. Chem. Res.42(8), 1141–1151 (2009).
  • Menjoge AR , KannanRM, TomaliaDA. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov. Today15(5–6), 171–185 (2010).
  • Kukowska-Latallo JF , CandidoKA, CaoZYet al. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 65(12), 5317–5324 (2005).
  • Lim J , ChouaiA, LoST, LiuW, SunX, SimanekEE. Design, synthesis, characterization, and biological evaluation of triazine dendrimers bearing paclitaxel using ester and ester/disulfide linkages. Bioconjug. Chem.20(11), 2154–2161 (2009).
  • Zhang Y , ThomasTP, DesaiAet al. Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, “one pot” synthetic approach. Bioconjug. Chem. 21(3), 489–495 (2010).
  • Mullen DG , DesaiAM, WaddellJNet al. The implications of stochastic synthesis for the conjugation of functional groups to nanoparticles. Bioconjug. Chem. 19(9), 1748–1752 (2008).
  • Zong H , ThomasTP, LeeKHet al. Bifunctional PAMAM dendrimer conjugates of folic acid and methotrexate with defined ratio. Biomacromolecules 13(4), 982–991 (2012).
  • Okuda T , KawakamiS, MaeieT, NiidomeT, YamashitaF, HashidaM. Biodistribution characteristics of amino acid dendrimers and their PEGylated derivatives after intravenous administration. J. Control. Release114(1), 69–77 (2006).
  • Singh P , GuptaU, AsthanaA, JainNK. Folate and folate–PEG–PAMAM dendrimers: Synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice. Bioconjug. Chem.19(11), 2239–2252 (2008).
  • Wiener EC , BrechbielMW, BrothersHet al. Dendrimer-based metal-chelates – a new class of magnetic-resonance-imaging contrast agents. Magn. Reson. Med. 31(1), 1–8 (1994).
  • Malik N , EvagorouEG, DuncanR. Dendrimer-platinate: a novel approach to cancer chemotherapy. Anticancer Drugs10(8), 767–776 (1999).
  • Baker JR , QuintanaA, PiehlerL, Banazak-HollM, TomaliaD, RaczkaE. The synthesis and testing of anti-cancer therapeutic nanodevices. Biomed. Microdevices3(1), 61–69 (2001).
  • Myc A , DouceTB, AhujaNet al. Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates. Anticancer Drug 19(2), 143–149 (2008).
  • Haensler J , SzokaFC. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug. Chem.4(5), 372–379 (1993).
  • Vincent L , VaretJ, PilleJYet al. Efficacy of dendrimer-mediated angiostatin and TIMP-2 gene delivery on inhibition of tumor growth and angiogenesis: in vitro and in vivo studies. Int. J. Cancer 105(3), 419–429 (2003).
  • Xiao K , LiY, LuoJet al. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials 32(13), 3435–3446 (2011).
  • Sisson AL , SteinhilberD, RossowT, WelkerP, LichaK, HaagR. Biocompatible functionalized polyglycerol microgels with cell penetrating properties. Angew. Chem. Int. Ed.48(41), 7540–7545 (2009).
  • D‘Emanuele A , AttwoodD. Dendrimer-drug interactions. Adv. Drug Deliv. Rev.57(15), 2147–2162 (2005).
  • Karakoti AS , DasS, ThevuthasanS, SealS. PEGylated inorganic nanoparticles. Angew. Chem. Int. Ed.50(9), 1980–1994 (2011).
  • Xiao K , LiY, LeeJSet al. “OA02” peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo. Cancer Res. 72(8), 2100–2110 (2012).
  • Hua C , PengSM, DongCM. Synthesis and characterization of linear-dendron-like poly(ε-caprolactone)-β-poly(ethylene oxide) copolymers via the combination of ring-opening polymerization and click chemistry. Macromolecules41(18), 6686–6695 (2008).
  • Kostiainen MA , SzilvayGR, LehtinenJet al. Precisely defined protein-polymer conjugates: construction of synthetic DNA binding domains on proteins by using multivalent dendrons. Acs Nano 1(2), 103–113 (2007).
  • Deng JJ , ZhouYF, XuB, MaiKJ, DengYB, ZhangLM. Dendronized chitosan derivative as a biocompatible gene delivery carrier. Biomacromolecules12(3), 642–649 (2011).
  • Barnard A , PosoccoP, PriclSet al. Degradable self-assembling dendrons for gene delivery: experimental and theoretical insights into the barriers to cellular uptake. J. Am. Chem. Soc. 133(50), 20288–20300 (2011).
  • Wood KC , LittleSR, LangerR, HammondPT. A family of hierarchically self-assembling linear-dendritic hybrid polymers for highly efficient targeted gene delivery. Angew. Chem. Int. Ed.44(41), 6704–6708 (2005).
  • Yu HJ , NieY, DohmenC, LiYQ, WagnerE. Epidermal growth factor-PEG functionalized PAMAM-pentaethylenehexamine dendron for targeted gene delivery produced by click chemistry. Biomacromolecules12(6), 2039–2047 (2011).
  • Wood KC , AzarinSM, ArapW, PasqualiniR, LangerR, HammondPT. Tumor-targeted gene delivery using molecularly engineered hybrid polymers functionalized with a tumor-homing peptide. Bioconjug. Chem.19(2), 403–405 (2008).
  • Kojima C . Design of stimuli-responsive dendrimers. Expert Opin. Drug Deliv.7(3), 307–319 (2010).
  • Pantel K , BrakenhoffRH. Dissecting the metastatic cascade. Nat. Rev. Cancer4(6), 448–456 (2004).
  • Ring A , SmithIE, DowsettM. Circulating tumour cells in breast cancer. Lancet Oncol.5(2), 79–88 (2004).
  • Nagrath S , SequistLV, MaheswaranSet al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450(7173), 1235–1239 (2007).
  • Stott SL , HsuCH, TsukrovDIet al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc. Natl Acad. Sci. USA 107(43), 18392–18397 (2010).
  • He W , WangHF, HartmannLC, ChengJX, LowPS. In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry. Proc. Natl Acad. Sci. USA104(28), 11760–11765 (2007).
  • Dimitroff CJ , LechpammerM, Long-WoodwardD, KutokJL. Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Cancer Res.64(15), 5261–5269 (2004).
  • McNeeley KM , AnnapragadaA, BellamkondaRV. Decreased circulation time offsets increased efficacy of PEGylated nanocarriers targeting folate receptors of glioma. Nanotechnology18(38), 510 (2007).
  • McNeeley KM , KarathanasisE, AnnapragadaAV, BellamkondaRV. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors. Biomaterials30(23–24), 3986–3995 (2009).
  • Gabizon A , HorowitzAT, GorenD, TzemachD, ShmeedaH, ZalipskyS. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. Clin. Cancer Res.9(17), 6551–6559 (2003).
  • Danhier F , FeronO, PreatV. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control. Release148(2), 135–146 (2010).
  • Patri AK , MajorosIJ, BakerJR Jr. Dendritic polymer macromolecular carriers for drug delivery. Curr. Opin. Chem. Biol.6(4), 466–471 (2002).
  • Kukowska-Latallo JF , CandidoKA, CaoZet al. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 65(12), 5317–5324 (2005).
  • Tian L , HammondPT. Comb-dendritic block copolymers as tree-shaped macromolecular amphiphiles for nanoparticle self-assembly. Chem. Materials18(17), 3976–3984 (2006).
  • Gillies ER , FrechetJM. Designing macromolecules for therapeutic applications: polyester dendrimer-poly(ethylene oxide) “bow-tie” hybrids with tunable molecular weight and architecture. J. Am. Chem. Soc.124(47), 14137–14146 (2002).
  • Demattei CR , HuangB, TomaliaDA. Designed dendrimer syntheses by self-assembly of single-site, ssDNA functionalized dendrons. Nano Lett.4(5), 771–777 (2004).
  • Olson ES , JiangT, AguileraTAet al. Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases. Proc. Natl Acad. Sci. USA 107(9), 4311–4316 (2010).
  • Kobayashi H , KoyamaY, BarrettTet al. Multimodal nanoprobes for radionuclide and five-color near-infrared optical lymphatic imaging. ACS Nano. 1(4), 258–264 (2007).
  • Cheng Z , ThorekDLJ, TsourkasA. Gadolinium-conjugated dendrimer nanoclusters as a tumor-targeted T(1) magnetic resonance imaging contrast agent. Angew. Chem. Int. Ed.49(2), 346–350 (2010).
  • Kaneshiro TL , JeongEK, MorrellG, ParkerDL, LuZR. Synthesis and evaluation of globular Gd-DOTA-monoamide conjugates with precisely controlled nanosizes for magnetic resonance angiography. Biomacromolecules9(10), 2742–2748 (2008).
  • Herborn CU , BarkhausenJ, PaetschIet al. Coronary arteries: contrast-enhanced MR imaging with SH L 643A – experience in 12 volunteers. Radiology 229(1), 217–223 (2003).
  • Chisholm EJ , VassauxG, Martin-DuquePet al. Cancer-specific transgene expression mediated by systemic injection of nanoparticles. Cancer Res. 69(6), 2655–2662 (2009).
  • Almutairi A , RossinR, ShokeenMet al. Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis. Proc. Natl Acad. Sci. USA 106(3), 685–690 (2009).
  • Parrott MC , BenhabbourSR, SaabCet al. Synthesis, radiolabeling, and bio-imaging of high-generation polyester dendrimers. J. Am. Chem. Soc. 131(8), 2906–2916 (2009).
  • Zhu S , HongM, ZhangL, TangG, JiangY, PeiY. PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation. Pharm. Res.27(1), 161–174 (2010).
  • Yang WL , BarthRF, WuGet al. Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors. J. Neurooncol. 95(3), 355–365 (2009).
  • Yang W , BarthRF, WuGet al. Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors. J. Neurooncol. 95(3), 355–365 (2009).
  • Van Der Poll DG , Kieler-FergusonHM, FloydWCet al. Design, synthesis, and biological evaluation of a robust, biodegradable dendrimer. Bioconjug. Chem. 21(4), 764–773 (2010).
  • Dhanikula RS , ArgawA, BouchardJF, HildgenP. Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability. Mol. Pharm.5(1), 105–116 (2008).
  • Fox ME , GuillaudeuS, FrechetJMJ, JergerK, MacaraegN, SzokaFC. Synthesis and in vivo antitumor efficacy of PEGylated poly(L-lysine) dendrimer-camptothecin conjugates. Mol. Pharm.6(5), 1562–1572 (2009).
  • Kaminskas LM , McLeodVM, KellyBDet al. Doxorubicin-conjugated PEGylated dendrimers show similar tumoricidal activity but lower systemic toxicity when compared to PEGylated liposome and solution formulations in mouse and rat tumor models. Mol. Pharm. 9(3), 422–432 (2012).
  • Kaminskas LM , KellyBD, McLeodVMet al. Capping methotrexat α-carboxyl groups enhances systemic exposure and retains the cytotoxicity of drug conjugated PEGylated polylysine dendrimers. Mol. Pharm. 8(2), 338–349 (2011).
  • Kaminskas LM , KellyBD, McLeodVMet al. Characterisation and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker. J. Control. Release 152(2), 241–248 (2011).
  • Kaminskas LM , KellyBD, McLeodVMet al. Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-l-lysine dendrimers. Mol. Pharm. 6(4), 1190–1204 (2009).
  • Choe YH , ConoverCD, WuDCet al. Anticancer drug delivery systems: multi-loaded N-4-acyl poly(ethylene glycol) prodrugs of ara-C. II. Efficacy in ascites and solid tumors. J. Control. Release 79(1–3), 55–70 (2002).
  • Pasut G , ScaramuzzaS, SchiavonO, MendichiR, VeroneseFM. PEG-epirubicin conjugates with high drug loading. J. Bioactive Compatible Polymers20(3), 213–230 (2005).
  • Vandamme TF , BrobeckL. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J. Control. Release102(1), 23–38 (2005).
  • Ke W , ZhaoY, HuangR, JiangC, PeiY. Enhanced oral bioavailability of doxorubicin in a dendrimer drug delivery system. J. Pharm. Sci.97(6), 2208–2216 (2008).
  • Florence AT , SakthivelT, TothI. Oral uptake and translocation of a polylysine dendrimer with a lipid surface. J. Control. Release65(1–2), 253–259 (2000).
  • Hayder M , PoupotM, BaronMet al. A phosphorus-based dendrimer targets inflammation and osteoclastogenesis in experimental arthritis. Sci. Transl. Med. 3(81), 81ra35 (2011).
  • Chandrasekar D , SistlaR, AhmadFJ, KharRK, DiwanPV. Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery. J. Biomed. Mater. Res. Part A.82A(1), 92–103 (2007).
  • Chandrasekar D , SistlaR, AhmadFJ, KharRK, DiwanPV. The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats. Biomaterials28(3), 504–512 (2007).
  • Chauhan AS , SrideviS, ChalasaniKBet al. Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. J. Control. Release 90(3), 335–343 (2003).
  • Yiyun C , NaM, TongwenXet al. Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers. J. Pharm. Sci. 96(3), 595–602 (2007).
  • Taratula O , GarbuzenkoOB, KirkpatrickPet al. Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery. J. Control. Release 140(3), 284–293 (2009).
  • Defoort JP , NardelliB, HuangWL, HoDD, TamJP. Macromolecular assemblage in the design of a synthetic AIDS vaccine. Proc. Natl Acad. Sci. USA89(9), 3879–3883 (1992).
  • Bernstein DI , BourneN, AyisiNKet al. Evaluation of formulated dendrimer SPL7013 as a microbicide. Antiviral Res. 57(3), A66–A66 (2003).
  • Jiang YH , EmauP, CairnsJSet al. SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6P in macaques. AIDS Res. Hum. Retroviruses 21(3), 207–213 (2005).
  • Daftarian P , KaiferAE, LiWet al. Peptide-conjugated PAMAM dendrimer as a universal DNA vaccine platform to target antigen-presenting cells. Cancer Res. 71(24), 7452–7462 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.